Fennec Pharmaceuticals (FENC) Other Operating Expenses (2016 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Other Operating Expenses came in at -$10.5 million in Q4 2025, down 1559.81% YoY from $719000.0 in Q4 2024, and down 1623.37% on a QoQ basis from $689000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Other Operating Expenses (2016 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 5 years of Other Operating Expenses data on file, last reported at -$10.5 million in Q4 2025.
- Quarterly Other Operating Expenses fell 1559.81% year-over-year to -$10.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.0 million (down 146.21% YoY) and the FY2025 annual result came in at $4.0 million, up 14.98% from the prior year.
- Other Operating Expenses retreated to -$10.5 million in Q4 2025, from $689000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $5.8 million in Q1 2024 to a low of -$10.5 million in Q4 2025.
- A 4-year average of $532500.0 and a median of $1.1 million in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 595.56% in 2025, down 1559.81% in 2025.
- Tracing FENC's Other Operating Expenses over 4 years: stood at $2.8 million in 2022, then soared by 63.48% to $4.6 million in 2023, then slumped by 84.21% to $719000.0 in 2024, then slumped by 1559.81% to -$10.5 million in 2025.
- The last three Other Operating Expenses figures came in at -$10.5 million (Q4 2025), $689000.0 (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 839,000.00 |
| Dec 31, 2025 | -10.50 Mn |
| Sep 30, 2025 | 689,000.00 |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 467,000.00 |
| Dec 31, 2024 | 719,000.00 |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 765,000.00 |
| Mar 31, 2024 | 5.76 Mn |
| Dec 31, 2023 | 4.55 Mn |
| Sep 30, 2023 | 343,000.00 |
| Jun 30, 2023 | 2.49 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Jun 30, 2022 | -10.02 Mn |
| Sep 30, 2016 | 40,000.00 |